TISSUSE GMBH

Company Overview

TissUse is a Berlin, Germany-based biotechnology company that has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissues. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse’s multi-organ chips provide a new approach to predict, for example, toxicity, ADME profiles, and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials.

TissUse has developed a unique, proprietary, and patent-protected “human-on-a-chip” technology platform to accelerate the development of pharmaceutical, chemical, cosmetics, and personalized medical products. This technology – for the first time– provides preclinical insight on a systemic level using human tissue and enables the direct prediction of the effects of chemicals and their metabolism on near real-life models.

TissUse offers high-value service contracts to create custom solutions for the safety evaluation of drugs, cosmetics, and chemicals and pre-clinical human disease modeling. Any new chip design serving customer needs with a specific organ arrangement can be prototyped and produced at short notice due to a proprietary rapid prototyping procedure established at TissUse. The versatile TissUse approach addresses multiple organs and tissues to make the right chip for the assay. The company has a HUMIMIC AutoPlant device to improve the research outputs in the development stages.

Company's Business Segments

• Products : Devices, Chips, Accessories and Cells, Others
• Services : Custom Solutions for the Safety Evaluation of Drugs, Cosmetics and Chemicals, Pre-Clinical Human Disease Modelling, Others